Treatment of Cardiovascular Disease With Low Dose Rivaroxaban in Advanced Chronic Kidney Disease

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1753 participants.

Also called NCT03969953

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,753 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03969953
Other papers using this trial's data
  • Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical Trial JAMA, 2026-07-28 DOI, PubMed 42240165, PMC13237706 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Australia, Belgium, Canada, France, Germany, India, Malaysia, Nepal, Saudi Arabia, Singapore, Taiwan, Tunisia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03969953. Randomized; quadruple masking; primary purpose treatment. Start 2021-01-18 (actual); primary completion 2025-10-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Treatment of Cardiovascular Disease With Low Dose Rivaroxaban in Advanced Chronic Kidney Disease
Acronym
TRACK
Condition
Chronic Kidney Diseases
Condition
Dialysis-dependent Kidney Failure
Condition
Cardiovascular Disease
Intervention (Drug)
Rivaroxaban 2.5 Mg Oral Tablet
Intervention (Other)
Placebo
Lead sponsor
The George Institute (class: other)
Collaborator
Emerald Clinical Inc. (class: industry)
Collaborator
Bayer (class: industry)
Collaborator
Central Hospital, Nancy, France (class: other)
Collaborator
King Abdullah International Medical Research Center (class: other)

Record details

Record id
cardio:ct-nct03969953
Content hash
efc765b15acbdb97f628bc54ef28a7443d91b13d601327fdfad17b25eed11178